MAX
Company Analysis Glaukos Corporation
1. Summary
Advantages
- Price (96.61 $) is less than fair price (104.09 $)
- The stock's return over the last year (-2.72%) is higher than the sector average (-7.4%).
- Current debt level 10.61% is below 100% and has decreased over 5 years from 18.84%.
- The company's current efficiency (ROE=-23.83%) is higher than the sector average (ROE=-75.26%)
Disadvantages
- Dividends (0%) are below the sector average (1.32%).
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Glaukos Corporation | Healthcare | Index | |
|---|---|---|---|
| 7 days | -10.3% | -2.5% | -1.2% |
| 90 days | -15.1% | -6.6% | -2.6% |
| 1 year | -2.7% | -7.4% | 11.4% |
GKOS vs Sector: Glaukos Corporation has outperformed the "Healthcare" sector by 4.68% over the past year.
GKOS vs Market: Glaukos Corporation has significantly underperformed the market by -14.09% over the past year.
Stable price: GKOS is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: GKOS with weekly volatility of -0.0523% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Below fair price: The current price (96.61 $) is lower than the fair price (104.09 $).
Price not significantly lower than the fair price: The current price (96.61 $) is slightly lower than the fair price by 7.7%.
5.2. P/E
P/E vs Sector: The company's P/E (-32.9) is lower than that of the sector as a whole (138.45).
P/E vs Market: The company's P/E (-32.9) is lower than that of the market as a whole (64.97).
5.3. P/BV
P/BV vs Sector: The company's P/BV (10.28) is lower than that of the sector as a whole (14.69).
P/BV vs Market: The company's P/BV (10.28) is lower than that of the market as a whole (20.2).
5.3.1 P/BV Similar companies
5.5. P/S
P/S vs Sector: The company's P/S indicator (20.57) is higher than that of the sector as a whole (14.16).
P/S vs Market: The company's P/S indicator (20.57) is lower than that of the market as a whole (30.87).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-100.75) is lower than that of the sector as a whole (60.1).
EV/Ebitda vs Market: The company's EV/Ebitda (-100.75) is lower than that of the market as a whole (35.11).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Rising and has grown by 38.55% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (38.55%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-35.32%).
6.4. ROE
ROE vs Sector: The company's ROE (-23.83%) is higher than that of the sector as a whole (-75.26%).
ROE vs Market: The company's ROE (-23.83%) is lower than that of the market as a whole (50.18%).
6.6. ROA
ROA vs Sector: The company's ROA (-15.29%) is lower than that of the sector as a whole (6.5%).
ROA vs Market: The company's ROA (-15.29%) is lower than that of the market as a whole (11.55%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (-2.46%) is lower than that of the sector as a whole (21.17%).
ROIC vs Market: The company's ROIC (-2.46%) is lower than that of the market as a whole (45.55%).
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
8. Dividends
8.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.32%.
8.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
9. Insider trades
9.1. Insider trading
Insider Buying Exceeds insider sales by 49.35% over the last 3 months.
9.2. Latest transactions
| Transaction date | Insider | Type | Price | Volume | Quantity |
|---|---|---|---|---|---|
| 09.02.2026 | Burns Thomas William CHAIRMAN & CEO |
Purchase | 30.92 | 513 | 166 000 |
| 22.01.2026 | Gilliam Joseph E PRESIDENT & COO |
Sale | 127.68 | 134 | 10 498 |
| 22.01.2026 | Gilliam Joseph E PRESIDENT & COO |
Purchase | 55.18 | 57 928 | 10 498 |
| 22.01.2026 | Stapley Marc Director |
Sale | 127.71 | 192 | 15 000 |
| 22.01.2026 | Stapley Marc Director |
Purchase | 24.69 | 37 035 | 15 000 |
Based on sources: porti.ru
